Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carl Icahn’s Extremely Modest Investment

Carl Icahn is one of the most well-known activist investors around. We especially like tracking activist investors because they come with their built-in catalysts. Most value investors are able to find bargains, but a bargain that stays a bargain isn’t really a bargain. Activist investors make things happen.

Carl Icahn

Carl Icahn recently disclosed his portfolio activity. His huge Motorola stake has been transformed into $1.4 Billion Motorola Solutions (MSI) and $650 Million Motorola Mobility (MMI) stakes. The largest new position in Icahn’s portfolio is Clorox (CLX) with a $700 Million position. Icahn also had $55 Million in Amgen (AMGN) and $5 Million in Southern Union (SUG).

Icahn disclosed his Clorox stake on February 11th in a 13D filing and the stock closed above $70 that day. The following day the stock price went back down to $66. Yesterday Clorox closed at $70.57, so the stock price didn’t move much. Jim Simons’ Renaissance, Cint Carlson’s Carlson Capital, Phill Gross’ Adage, and Lance Helfert’s West Coast Asset Management had small positions in Clorox before Icahn disclosed his huge stake. By the end of first quarter Renaissance, Carlson and Adage sold their entire stake in Clorox, and West Coast Asset Management cut its stake by half. This implies that Clorox doesn’t have a lot of upside and Icahn made his Clorox investment targeting only a small profit (around 10%).

The table below summarizes Icahn Capital’s portfolio activity during the first quarter of 2011:

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!